Wenya Shao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wenya Shao has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Huangyuan Li
Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, China
4 shared publications - Siying Wu
Fujian Medical University
3 shared publications Fuli Zheng
Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China
2 shared publications- Fuli Zheng
Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou, 350108, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou, 350108, China
2 shared publications Guangxia Yu
Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China
2 shared publicationsHong Hu
Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China
2 shared publications
Latest Publications
- Open Access
- 21 May 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 299, 118364
Characterizing microglial heterogeneity in autophagy impairment of Paraquat-induced Parkinson’s disease-like neurodegeneration
- 21 May 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 299, 118364
Open AccessCharacterizing microglial heterogeneity in autophagy impairment of Paraquat-induced Parkinson’s disease-like neurodegeneration
- Open Access
- 1 May 2025
- Published by China Science Publishing & Media Ltd. in Chinese Journal of Chromatography
- Vol. 43 (5) , 487-497
Recent advances on the role of exosomes in neurodegenerative diseases
Exosomes are nano-sized, lipid bilayer vesicles secreted by cells. They carry essential bioactive molecules, such as proteins, nucleic acids, and lipids, and are widely present in bodily fluids including blood and cerebrospinal fluid. Exosomes transfer bioactive molecules to target cells through various mechanisms, including endocytosis, ligand-receptor interactions, or direct membrane fusion, and play crucial roles in intercellular communication, including facilitating intercellular information exchange, maintaining nerve-cell function, participating in immune responses, and providing nutritional support. Exosomes significantly promote signal transmission and intercellular communication in the central nervous system and are involved in the pathogenesis and development of diseases by participating in the spread of pathological proteins, regulating neuroinflammation, and the deposition of pathological proteins. Therefore, exosomes play key roles in the occurrence and development of neurodegenerative diseases, and their contents, especially proteins and miRNAs, are specific for given pathological and physiological states and are relatively stable during extraction and analysis. Hence, exosomes are ideal tools for diagnosing diseases, staging their courses, and assisting prognosis. This article further explores exosomes derived from blood, saliva, urine, and cerebrospinal fluid as potential diagnostic biomarkers for neurodegenerative diseases. As natural drug-delivery systems, exosomes have the advantages of biocompatibility, ability to cross biological barriers, target specificity, stability, and containing natural therapeutic molecules, which can effectively improve the precision and efficacy of drug delivery and reduce side effects, making them an ideal carrier for delivering drugs to the central nervous system. Therefore, exosomes hold great potential in the diagnosis and treatment of central nervous system diseases. This article systematically reviews the latest advances in exosome research directed toward specific neurodegenerative diseases, focusing on their roles played in disease pathogenesis, progression, diagnosis, and treatment, with the aim of providing theoretical support and a reference for the early diagnosis and treatment of these diseases.
- 1 May 2025
- Published by China Science Publishing & Media Ltd. in Chinese Journal of Chromatography
- Vol. 43 (5) , 487-497
Open AccessRecent advances on the role of exosomes in neurodegenerative diseases
Exosomes are nano-sized, lipid bilayer vesicles secreted by cells. They carry essential bioactive molecules, such as proteins, nucleic acids, and lipids, and are widely present in bodily fluids including blood and cerebrospinal fluid. Exosomes transfer bioactive molecules to target cells through various mechanisms, including endocytosis, ligand-receptor interactions, or direct membrane fusion, and play crucial roles in intercellular communication, including facilitating intercellular information exchange, maintaining nerve-cell function, participating in immune responses, and providing nutritional support. Exosomes significantly promote signal transmission and intercellular communication in the central nervous system and are involved in the pathogenesis and development of diseases by participating in the spread of pathological proteins, regulating neuroinflammation, and the deposition of pathological proteins. Therefore, exosomes play key roles in the occurrence and development of neurodegenerative diseases, and their contents, especially proteins and miRNAs, are specific for given pathological and physiological states and are relatively stable during extraction and analysis. Hence, exosomes are ideal tools for diagnosing diseases, staging their courses, and assisting prognosis. This article further explores exosomes derived from blood, saliva, urine, and cerebrospinal fluid as potential diagnostic biomarkers for neurodegenerative diseases. As natural drug-delivery systems, exosomes have the advantages of biocompatibility, ability to cross biological barriers, target specificity, stability, and containing natural therapeutic molecules, which can effectively improve the precision and efficacy of drug delivery and reduce side effects, making them an ideal carrier for delivering drugs to the central nervous system. Therefore, exosomes hold great potential in the diagnosis and treatment of central nervous system diseases. This article systematically reviews the latest advances in exosome research directed toward specific neurodegenerative diseases, focusing on their roles played in disease pathogenesis, progression, diagnosis, and treatment, with the aim of providing theoretical support and a reference for the early diagnosis and treatment of these diseases.
- Open Access
Zirconium-Modified Attapulgite Composite for Phosphorus Removal and Algae Control in Lake Water
Phosphorus removal is critical for effective water treatment and the prevention of eutrophication. This study focuses on the modification of attapulgite, an economical clay material, with zirconium (Zr@ATP) to enhance its phosphorus adsorption capacity. Zr@ATP was comprehensively characterized, and its phosphorus-removal mechanisms were investigated. Additionally, its performance in water treatment was evaluated using a lake water-sediment system. Zr@ATP exhibited a high surface area of 329.29 m2/g. The static adsorption experiments revealed that Zr@ATP achieved a phosphorus-removal efficiency of 95.8% at an adsorbent dosage of 5 g/L. Kinetic studies indicated that the adsorption followed a pseudo-second-order model, with the primary mechanism being chemisorption via ion exchange. Application of Zr@ATP in a lake water-sediment system resulted in an 83.6% reduction in total phosphorus. The chlorophyll concentration significantly decreased from 32.33 μg/L to 8.56 μg/L, and the algal density decreased by 84.6%, effectively inhibiting algal growth. These results suggest that Zr@ATP is a promising adsorbent for sustainable phosphorus removal and eutrophication control in aquatic environments.
Open AccessZirconium-Modified Attapulgite Composite for Phosphorus Removal and Algae Control in Lake Water
Phosphorus removal is critical for effective water treatment and the prevention of eutrophication. This study focuses on the modification of attapulgite, an economical clay material, with zirconium (Zr@ATP) to enhance its phosphorus adsorption capacity. Zr@ATP was comprehensively characterized, and its phosphorus-removal mechanisms were investigated. Additionally, its performance in water treatment was evaluated using a lake water-sediment system. Zr@ATP exhibited a high surface area of 329.29 m2/g. The static adsorption experiments revealed that Zr@ATP achieved a phosphorus-removal efficiency of 95.8% at an adsorbent dosage of 5 g/L. Kinetic studies indicated that the adsorption followed a pseudo-second-order model, with the primary mechanism being chemisorption via ion exchange. Application of Zr@ATP in a lake water-sediment system resulted in an 83.6% reduction in total phosphorus. The chlorophyll concentration significantly decreased from 32.33 μg/L to 8.56 μg/L, and the algal density decreased by 84.6%, effectively inhibiting algal growth. These results suggest that Zr@ATP is a promising adsorbent for sustainable phosphorus removal and eutrophication control in aquatic environments.
- 24 April 2024
- Published by Elsevier in Environmental Pollution
- Vol. 352, 124035
Microglial exosomes in paraquat-induced Parkinson's disease: Neuroprotection and biomarker clues
- 24 April 2024
- Published by Elsevier in Environmental Pollution
- Vol. 352, 124035
Microglial exosomes in paraquat-induced Parkinson's disease: Neuroprotection and biomarker clues
- Open Access
- 15 August 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 263, 115356
Microglia-derived exosomal circZNRF1 alleviates paraquat-induced neuronal cell damage via miR-17-5p
- 15 August 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 263, 115356
Open AccessMicroglia-derived exosomal circZNRF1 alleviates paraquat-induced neuronal cell damage via miR-17-5p
- Open Access
- 1 January 2021
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 208, 111424
Inflammatory lncRNA AK039862 regulates paraquat-inhibited proliferation and migration of microglial and neuronal cells through the Pafah1b1/Foxa1 pathway in co-culture environments
- 1 January 2021
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 208, 111424
Open AccessInflammatory lncRNA AK039862 regulates paraquat-inhibited proliferation and migration of microglial and neuronal cells through the Pafah1b1/Foxa1 pathway in co-culture environments